reference/10566313

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10566313

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article
endingPage	262
issn	1432-0584 0939-5555
issueIdentifier	4
pageRange	257-262
publicationName	Annals of Hematology
startingPage	257
bibliographicCitation	Park YH, Lee JJ, Ryu MH, Kim SY, Kim DH, Do YR, Lee KH, Oh SJ, Kim YK, Suh CW, Heo DS, Ryoo BY, Kim JK, Song HS, Lee WS, Kim HJ, Bang YJ, Yang SH, Sohn SK, Kang YK; Lymphoma Study Division of the Korean Cancer Study Group. Improved therapeutic outcomes of DLBCL after introduction of rituximab in Korean patients. Ann Hematol. 2006 Apr;85(4):257–62. doi: 10.1007/s00277-005-0060-6. PMID: 16416337.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_020dcd64c04040d83acb90f0bcea3117 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_449bdacc7e654b59c63a7cd9662f62dd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9611bf27ce1a6c2ba40477ee1bc0ad8f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_12dc07c45a1bc9aaec7e3d5a8d1b001c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1d10f28fb4abce897cf769cba0df0a90 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7823f670da7b18387edf8308e76ff6da http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f42c1bdb8ce0272386bc784262f39189 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0923f66aed0e325817fefb5863e853c5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_be0dfef6f5a8637b820a90d7369be673 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3260edca44ca91e3071c4fcb56a549e3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e0093726822e0805614fd8a36c55cd04 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6fdbefb1fa6afca41ae16c0b119cc1d9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8aed325e70504ada7271dfcebafcf54 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_03a4c2e813006b26d0bfd3c9ca9c121f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9db18723f3c54f41ab2754986c58f6aa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_060154464c46af496a44c4f8636eabfa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_05258dd71f04f2d071ddaa0315b93bbd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c99eab35d962166d721c8a6aba5ed501 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_38b496db793a42e618a37d851190dbb0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4c500d8a4bb0dc38486c6d70a2904d25
date	2006-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1007/s00277-005-0060-6 https://pubmed.ncbi.nlm.nih.gov/16416337
isPartOf	https://portal.issn.org/resource/ISSN/0939-5555 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1088 https://portal.issn.org/resource/ISSN/1432-0584
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ https://scigraph.springernature.com/
title	Improved therapeutic outcomes of DLBCL after introduction of rituximab in Korean patients
discusses	http://id.nlm.nih.gov/mesh/M0017465 http://id.nlm.nih.gov/mesh/M0022676 http://id.nlm.nih.gov/mesh/M0005485 http://id.nlm.nih.gov/mesh/M0244307 http://id.nlm.nih.gov/mesh/M0544940 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0006784
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134755071 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3717450 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45358158 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296921 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9859 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62313 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388993 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324671 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164145 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8390 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8388 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275

Total number of triples: 63.